Review
doi: 10.1007/s10555-007-9070-2.
Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells
Affiliations
- PMID: 17786539
- DOI: 10.1007/s10555-007-9070-2
Item in Clipboard
Review
Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells
Cancer Metastasis Rev.
2007 Dec.
Abstract
Vascular endothelial growth factor (VEGF) has been shown to be the major mediator of physiologic and pathologic angiogenesis. VEGF was initially thought to be an endothelial cell specific ligand, but recently, VEGF has been shown to mediate tumor cell function via activation of receptors on tumor cells themselves. Here, we review the expression patterns and binding profiles of the VEGF receptors and their ligands on gastrointestinal tumor cells. Furthermore, we describe the current knowledge in regards to the function of these receptors on tumor cells. Elucidating the function of VEGF receptors on tumor cells should help us to better understand the potential mechanisms of action of anti-VEGF therapies.
Similar articles
-
Vascular endothelial growth factor receptors: expression and function in solid tumors.Clin Adv Hematol Oncol. 2004 Jan;2(1):37-45. Clin Adv Hematol Oncol. 2004. PMID: 16163158 Review.
-
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.J Clin Oncol. 2005 Feb 10;23(5):1011-27. doi: 10.1200/JCO.2005.06.081. Epub 2004 Dec 7. J Clin Oncol. 2005. PMID: 15585754 Review.
-
Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors.APMIS. 2004 Apr-May;112(4-5):257-63. doi: 10.1111/j.1600-0463.2004.apm11204-0505.x. APMIS. 2004. PMID: 15233640
-
EGFR/VEGF signalling pathway in colorectal cancer: the way we are!Bull Cancer. 2005 Aug;92(Spec no):S3-4. Bull Cancer. 2005. PMID: 16387661 English, French. No abstract available.
-
Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.FEBS J. 2009 Sep;276(17):4636-43. doi: 10.1111/j.1742-4658.2009.07175.x. Epub 2009 Jul 31. FEBS J. 2009. PMID: 19664071 Review.
Cited by
-
Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.Oncotarget. 2015 Oct 13;6(31):31050-68. doi: 10.18632/oncotarget.2910. Oncotarget. 2015. PMID: 25682871 Free PMC article.
-
RETRACTED: Differential effects of VEGFR-1 and VEGFR-2 inhibition on tumor metastases based on host organ environment.Cancer Res. 2010 Nov 1;70(21):8357-67. doi: 10.1158/0008-5472.CAN-10-1138. Epub 2010 Oct 26. Cancer Res. 2010. Retraction in: Cancer Res. 2024 Oct 15;84(20):3490. doi: 10.1158/0008-5472.CAN-24-3248 PMID: 20978198 Free PMC article. Retracted.
-
Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells.Cancer Res. 2016 May 15;76(10):3014-24. doi: 10.1158/0008-5472.CAN-15-1605. Epub 2016 Mar 17. Cancer Res. 2016. PMID: 26988990 Free PMC article.
-
Comparison of efficacy and toxicity of bevacizumab, endostar and apatinib in transgenic and human lung cancer xenograftzebrafish model.Sci Rep. 2018 Oct 26;8(1):15837. doi: 10.1038/s41598-018-34030-5. Sci Rep. 2018. PMID: 30367145 Free PMC article.
-
Effect of renin-angiotensin system inhibitors in patients with cancer treated with anti-VEGF therapy.Open Heart. 2022 Dec;9(2):e002135. doi: 10.1136/openhrt-2022-002135. Open Heart. 2022. PMID: 36600585 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
